Uncompassionate use: the inconsistent offering of life-saving unlicensed medicines
The Pharmaceutical Journal from the Royal Pharmaceutical Society
Stay updated with breaking news from Access Pathway. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Pharmaceutical Journal from the Royal Pharmaceutical Society
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorizations for Pombliti + Opfolda, a two-component therapy to treat Pompe disease.
Transaction led by healthcare specialist investors, TCGX and Aisling Capital $125 million financing upfront with up to an additional $160 million tied to exercise of warrants Net proceeds... -Today at 08:59 am- MarketScreener
Transaction led by healthcare specialist investors, TCGX and Aisling Capital $125 million financing upfront with up to an additional $160 million...
Transaction led by healthcare specialist investors, TCGX and Aisling Capital